Shanghai Pharmaceutical plans to acquire Cardinal Health China business from US-based healthcare company Cardinal Health for $1.2bn.
The divestiture will enable the Chinese pharmaceutical company to strengthen its distribution network.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Sapphire I (HK) Holdings has acquired a 49% stake in Chinese pharmaceutical company Hisun-Pfizer Pharmaceuticals from Pfizer.
The divestment enables both Hisun and Pfizer to concentrate on their core businesses.
Sumitomo Corporation of America (SCA) plans to acquire a 20% stake in US-based generic drug manufacturer Sawai America Inc (SAI) from Sawai Pharmaceutical (SPCL) for $211m.
SCA, a subsidiary of Sumitomo Corporation, is a transport and logistics services provider, while SPCL is a generic pharmaceuticals manufacturer.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataBoth companies involved in the acquisition are based in Japan.
Grupo Biotoscana SL has acquired pharmaceutical manufacturer Laboratorio DOSA S.A. for BRL100m ($30.48m).
The acquisition will enable the specialist therapeutic products developer to expand its product portfolio and geographic reach.
